Opko Health (OPK) Liabilities and Shareholders Equity (2010 - 2026)
Opko Health's (OPK) quarterly Liabilities and Shareholders Equity came in at $1.8 billion in Q2 2026, down 7.28% on a YoY basis from $2.0 billion in Q2 2025, and down 1.47% quarter-over-quarter from $1.9 billion in Q1 2026.
Opko Health (OPK) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Opko Health (OPK) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 7.28% year-over-year to $1.8 billion; the trailing twelve-month figure through Jun 2026 stood at $7.6 billion (down 11.03% YoY), and the FY2025 full-year result was $1.9 billion, down 12.19% from the prior year.
- Liabilities and Shareholders Equity fell to $1.8 billion in Q2 2026 per OPK's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $2.4 billion in Q2 2022 and bottomed at $1.8 billion in Q2 2026.
- Historically, Liabilities and Shareholders Equity has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2023.
- The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity advanced 9.7% in 2024, then dropped 12.76% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then declined by 7.18% to $2.0 billion in 2023, then climbed by 9.37% to $2.2 billion in 2024, then decreased by 12.19% to $1.9 billion in 2025, then declined by 5.31% to $1.8 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.8 billion, $1.9 billion, and $1.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 87.63 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 150.01 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 4.32 Bn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 9.18 Bn |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | 1.83 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Bn |
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 2.00 Bn |
| Jun 30, 2025 | 1.97 Bn |
| Mar 31, 2025 | 2.13 Bn |
| Dec 31, 2024 | 2.20 Bn |
| Sep 30, 2024 | 2.26 Bn |
| Jun 30, 2024 | 1.98 Bn |
| Mar 31, 2024 | 1.97 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Sep 30, 2023 | 2.06 Bn |
| Jun 30, 2023 | 2.16 Bn |
| Mar 31, 2023 | 2.17 Bn |
| Dec 31, 2022 | 2.17 Bn |
| Sep 30, 2022 | 2.22 Bn |
| Jun 30, 2022 | 2.37 Bn |
| Mar 31, 2022 | 2.31 Bn |
| Dec 31, 2021 | 2.40 Bn |
| Sep 30, 2021 | 2.42 Bn |
Opko Health Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=OPK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();